Skip to content

Drug interactions

Alemtuzumab + Fingolimod

Severity: Major

Alemtuzumab and Fingolimod: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Alemtuzumab causes profound and prolonged lymphocyte depletion, and fingolimod adds lymphocyte sequestration, which raises the risk of serious infection.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to see why Alemtuzumab and Fingolimod interact, what to do about it, and the sources.

  • Mechanism of action
  • Clinical management
  • Evidence level

Free 14-day trial. No card needed.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in